PubRank

D Delia

Author PubWeight™ 96.73‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Ubiquitous cell-surface glycoprotein on tumor cells is proliferation-associated receptor for transferrin. Proc Natl Acad Sci U S A 1981 4.50
2 Expression of the CD34 gene in vascular endothelial cells. Blood 1990 4.41
3 P53 expression in breast cancer. Int J Cancer 1988 3.51
4 Apoptosis inhibitory activity of cytoplasmic p21(Cip1/WAF1) in monocytic differentiation. EMBO J 1999 3.22
5 bcl-2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia. Blood 1993 2.45
6 Chk2 activation dependence on Nbs1 after DNA damage. Mol Cell Biol 2001 1.85
7 Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems. Cancer Res 1996 1.85
8 Isolation of human haematopoietic progenitor cells using monoclonal antibodies. Nature 1980 1.57
9 p53 activity and chemotherapy. Nat Med 1996 1.53
10 Acute lymphoblastic leukaemia associated antigen. IV. Expression on non-leukaemic 'lymphoid' cells. Leuk Res 1980 1.50
11 The tumor-suppressor gene FHIT is involved in the regulation of apoptosis and in cell cycle control. Proc Natl Acad Sci U S A 1999 1.47
12 The forkhead-associated domain of NBS1 is essential for nuclear foci formation after irradiation but not essential for hRAD50[middle dot]hMRE11[middle dot]NBS1 complex DNA repair activity. J Biol Chem 2001 1.43
13 Distinct morphophenotypic features of chronic B-cell leukaemias identified with CD1c and CD23 antibodies. Eur J Haematol 1991 1.39
14 A novel p53-inducible gene coding for a microtubule-localized protein with G2-phase-specific expression. EMBO J 1998 1.38
15 Cell size, cell cycle and transition probability in mouse fibroblasts. Cell 1978 1.28
16 Involvement of the multilineage CD38 molecule in a unique pathway of cell activation and proliferation. J Immunol 1990 1.28
17 Automatic microinjection system facilitates detection of growth inhibitory mRNA. Proc Natl Acad Sci U S A 1988 1.24
18 Dendritic cell maturation is required for initiation of the immune response. J Leukoc Biol 1997 1.22
19 Molecular features of CD34: a hemopoietic progenitor cell-associated molecule. Leukemia 1992 1.21
20 Differential expression of HLA-DR and DR-linked determinants on human leukemias and lymphoid cells. Eur J Immunol 1983 1.13
21 A monoclonal antibody specific for immature human hemopoietic cells and T lineage cells. J Immunol 1981 1.12
22 Overexpression of the Bcl-2 protein increases the half-life of p21Bax. J Biol Chem 1995 1.11
23 The A-Myb transcription factor is a marker of centroblasts in vivo. J Immunol 1998 1.10
24 Modulation of T leukaemic cell phenotype with phorbol ester. Int J Cancer 1982 1.09
25 4-Hydroxyphenyl retinamide is a highly selective activator of retinoid receptors. J Biol Chem 1996 1.07
26 Expression of cell-surface HLA-DR, HLA-ABC and glycophorin during erythroid differentiation. Nature 1981 1.07
27 Novel SMAC-mimetics synergistically stimulate melanoma cell death in combination with TRAIL and Bortezomib. Br J Cancer 2010 1.06
28 Minimal residual disease in acute lymphoblastic leukemia detected by immune selection and gene rearrangement analysis. J Clin Oncol 1989 1.02
29 DNA-damage response, survival and differentiation in vitro of a human neural stem cell line in relation to ATM expression. Cell Death Differ 2009 1.02
30 Human Thy-1 antigen: cell surface expression on early T and B lymphocytes. Immunology 1983 1.02
31 Identification of CD34+ cells in normal and pathological bone marrow biopsies by QBEND10 monoclonal antibody. Leukemia 1991 1.02
32 Defective control of apoptosis, radiosensitivity, and spindle checkpoint in ataxia telangiectasia. Cancer Res 1998 0.99
33 Flow cytometric detection of the mitochondrial BCL-2 protein in normal and neoplastic human lymphoid cells. Cytometry 1992 0.99
34 DNA damage-associated dysregulation of the cell cycle and apoptosis control in cells with germ-line p53 mutation. Cancer Res 1997 0.96
35 Differential susceptibility to HIV-GP120-sensitized apoptosis in CD4+ T-cell clones with different T-helper phenotypes: role of CD95/CD95L interactions. Blood 1997 0.95
36 Monoclonal antibody-defined surface markers of effector cells involved in human monocyte cytotoxicity. Cell Immunol 1984 0.95
37 Primary cutaneous gamma/delta T-cell lymphoma presenting as disseminated pagetoid reticulosis. J Invest Dermatol 1991 0.94
38 Classes I and II HLA and melanoma-associated antigen expression and modulation on melanoma cells isolated from primary and metastatic lesions. Cancer Res 1986 0.94
39 Sensitivity of human multiple myelomas and myeloid leukemias to the proteasome inhibitor I. Leukemia 2005 0.94
40 Differentiation-linked expression of cell surface markers on HL-60 leukemic cells. Blood 1980 0.94
41 Antibody for detecting p53 protein by immunohistochemistry in normal tissues. J Clin Pathol 1994 0.94
42 Characterization of the response of human thymocytes and blood lymphocytes to the synergistic mitogenicity of 12-O-tetradecanoylphorbol-13-acetate (TPA)-ionomycin. Eur J Immunol 1984 0.93
43 Defective control of apoptosis and mitotic spindle checkpoint in heterozygous carriers of ATM mutations. Cancer Res 1999 0.92
44 Role of apoptosis and apoptosis-related proteins in the cisplatin-resistant phenotype of human tumor cell lines. Apoptosis 1997 0.92
45 Expression of the OKT monoclonal antibody defined antigenic determinants in malignancy. Int J Immunopharmacol 1981 0.92
46 A novel Leu153Ser mutation of the Fanconi anemia FANCD2 gene is associated with severe chemotherapy toxicity in a pediatric T-cell acute lymphoblastic leukemia. Leukemia 2006 0.91
47 A6--a new 45RO monoclonal antibody for immunostaining of paraffin-embedded tissues. Am J Clin Pathol 1991 0.90
48 CDKN2A and CDK4 mutation analysis in Italian melanoma-prone families: functional characterization of a novel CDKN2A germ line mutation. Br J Cancer 2001 0.90
49 PCR-based clonality analysis: a reliable method for the diagnosis and follow-up monitoring of conservatively treated gastric B-cell MALT lymphomas? Histopathology 1999 0.90
50 Establishment and molecular characterization of a novel leukemic cell line with Philadelphia chromosome expressing p230 BCR/ABL fusion protein. Cancer Res 1995 0.89
51 GM-1, a clone of the monoblastic phagocyte U937 that expresses a large respiratory burst capacity upon activation with interferon-gamma. J Leukoc Biol 1991 0.89
52 Lineage relationship of chronic lymphocytic leukemia and hairy cell leukemia: studies with TPA. Leuk Res 1984 0.88
53 Exploitation of monoclonal antibodies: a "who's who" of haemopoietic malignancy. Blood Cells 1981 0.88
54 Expression of A-myb, but not c-myb and B-myb, is restricted to Burkitt's lymphoma, sIg+ B-acute lymphoblastic leukemia, and a subset of chronic lymphocytic leukemias. Blood 1996 0.88
55 Reciprocal expression of CD34 and cell adhesion molecule ELAM-1 on vascular endothelium in acute cutaneous graft-versus-host disease. J Pathol 1993 0.87
56 Identification of a novel human kinesin-related gene (HK2) by the cDNA differential display technique. Genomics 1997 0.87
57 Smac mimetics induce inflammation and necrotic tumour cell death by modulating macrophage activity. Cell Death Dis 2013 0.86
58 The apoptogenic response of human myeloid leukaemia cell lines and of normal and malignant haematopoietic progenitor cells to the proteasome inhibitor PSI. Br J Haematol 2001 0.85
59 A computer algorithm for the analysis of protein distribution in budding yeast. Cytometry 1984 0.84
60 Terminal deoxynucleotidyl transferase-positive B cell precursors in fetal lymph nodes and extrahemopoietic tissues. Eur J Immunol 1989 0.84
61 Bimodal regulation of p21(waf1) protein as function of DNA damage levels. Cell Cycle 2014 0.84
62 Large granular lymphocytes from murine blood and intestinal epithelium: comparison of surface antigens, natural killer activity, and morphology. Clin Immunol Immunopathol 1985 0.84
63 Progression of a myelodysplastic syndrome to pre-B acute lymphoblastic leukaemia with unusual phenotype. Br J Haematol 1986 0.83
64 IL-12 inhibits apoptosis induced in a human Th1 clone by gp120/CD4 cross-linking and CD3/TCR activation or by IL-2 deprivation. Cell Immunol 1995 0.83
65 In vitro inhibition of endothelial cell growth by the antiangiogenic drug AGM-1470 (TNP-470) and the anti-endoglin antibody TEC-11. Anticancer Drugs 1997 0.83
66 PCR analysis of IgH and BCL2 gene rearrangement in the diagnosis of follicular lymphoma in lymph node fine-needle aspiration. A critical appraisal. Diagn Mol Pathol 1997 0.83
67 Lack of TdT and immunoglobulin and T-cell receptor gene rearrangements in Hodgkin's disease. Int J Biol Markers 1988 0.83
68 pRb and Cdk regulation by N-(4-hydroxyphenyl)retinamide. Oncogene 2000 0.82
69 Analysis of leukocyte antigens detected by immunoenzymatic staining on human bone marrow colonies. Exp Hematol 1988 0.82
70 The antisense bcl-2-IgH transcript is an optimal target for synthetic oligonucleotides. Proc Natl Acad Sci U S A 1997 0.82
71 p53 in drug resistance in ovarian cancer. Lancet 1997 0.81
72 Morphologic, immunologic, and cytogenetic characteristics of secondary acute unclassifiable leukemia in Hodgkin's disease. Tumori 1988 0.80
73 The contribution of molecular biology in the diagnosis of human lymphomas. Diagn Immunol 1986 0.80
74 Up-regulation of prosaposin by the retinoid HPR and its effect on ceramide production and integrin receptors. FASEB J 2001 0.79
75 Murine neural stem cells model Hunter disease in vitro: glial cell-mediated neurodegeneration as a possible mechanism involved. Cell Death Dis 2013 0.78
76 Acute monoblastic leukemia as a second malignancy following chemotherapy for osteogenic sarcoma: a case report. Pediatr Hematol Oncol 1988 0.78
77 Phenotype of the terminal transferase-positive cells in human foetal liver and bone-marrow: analysis with monoclonal antibodies. Scand J Haematol 1984 0.78
78 Relevance of ultrastructural immunocytochemistry in the characterization of unclassifiable leukemias: correlation with phenotypic and genic studies. Haematologica 1989 0.78
79 Reticulohistiocytoma of the dorsum. J Am Acad Dermatol 1988 0.77
80 A cell cycle study of the effects of Con A on synchronized mouse embryo fibroblasts: arrest at two specific stages of the cycle and dissociation between uptake of thymidine and DNA synthesis. J Cell Sci 1980 0.77
81 Detection of the common acute lymphoblastic leukaemia antigen (CALLA) on B cells from human fetal tissues. A multiple phenotypic characterization. Clin Exp Immunol 1985 0.77
82 Synthesis and biological evaluation of dual action cyclo-RGD/SMAC mimetic conjugates targeting α(v)β(3)/α(v)β(5) integrins and IAP proteins. Org Biomol Chem 2014 0.77
83 Apoptosis induced by HIV-gp120 in a Th1 clone involves the generation of reactive oxygen intermediates downstream CD95 triggering. FEBS Lett 1997 0.76
84 Analysis of the binding of peanut agglutinin (PNA) to leukaemic cells and its relationship to T-cell differentiation. Immunology 1983 0.75
85 Allostimulation of patients' lymphocytes generates both T and NK-like cells cytotoxic for autologous melanoma. Br J Cancer 1985 0.75
86 Normalization of electrophoretic mobility of lymphocytes in patients with primary immunoglobulin deficiency treated with intravenous immunoglobulins. Acta Med Hung 1984 0.75
87 A cytogenetic, phenotypic, and molecular study of an immunoblastic lymphoma with a 14q + translocation. Cytogenet Cell Genet 1987 0.75
88 Analysis of tumor-specific immunoglobulin gene rearrangement in peripheral blood B-cells of multiple myeloma patients. Am J Hematol 1991 0.75
89 Acute leukemia with the (4;11) chromosome translocation following treatment for Hodgkin's disease: a case study. Haematologica 1988 0.75
90 Expression of differentiation and adhesion molecules in sporadic Burkitt's lymphoma. Hematol Oncol 1990 0.75
91 Monoclonal gammopathy (IgM-k) in a patient with Burkitt's type lymphoblastic lymphoma. Tumori 1984 0.75
92 [Alcoholization of splanchnic nerves guided by Doppler ultrasonography for neoplastic celiac pain]. Presse Med 1991 0.75
93 Expression of the T1 (CD5, p67) surface antigen in B-CLL and B-NHL and its correlation with other B-cell differentiation markers. Hematol Oncol 1986 0.75
94 TCR beta chain expression during human thymic development. Boll Soc Ital Biol Sper 1988 0.75
95 Clinical and laboratory findings in a new case of leukocyte adhesion deficiency. Haematologica 1990 0.75
96 Comparative antigenic phenotypes of normal and leukemic hemopoietic precursor cells analysed with a "library" of monoclonal antibodies. Haematol Blood Transfus 1981 0.75
97 Early cytoplasmic acidification in retinamide-mediated apoptosis of human promyelocytic leukemia cells. Biochem Biophys Res Commun 1996 0.75
98 [Expression of the CD1a, CD1b, CD1c antigens in human thymus at various ages of development]. Boll Soc Ital Biol Sper 1988 0.75
99 Mapping cell surface antigen expression of haemopoietic progenitor cells using monoclonal antibodies. Ciba Found Symp 1981 0.75